Nanochon

Repairing Your Active Life

Tokyo, United States · Founded 2016 · $24.6M raised

Headquarters
Tokyo
Employees
1–10
Founded
2016
Business Model
B2B
Total Funding
$24.6M
Last Round
$11.3M SeedMar 2026
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Nanochon is a medical device company advancing orthopedic care with Chondrograft™, a 3D-printed, off-the-shelf implant designed to repair cartilage damage in the knee. Targeting 'pre-replacement' patients — those with focal cartilage defects who need more than temporary relief but aren't yet candidates for joint replacement — Chondrograft uses nanomaterial and 3D-printed collagen-mimicking structures to draw in blood and active cells from underlying bone, supporting the body's natural healing processes. The company completed a $4.1M oversubscribed Seed Prime II round in early 2026 to fund its first-in-human clinical trial.

Summary

Nanochon is a Healthcare company based in Tokyo, United States, founded in 2016. It has raised $24.6M in total across 6 rounds, most recently a $11.3M Seed round in Mar 2026. Investors include cultivate(MD), Ecphora Capital and TEDCO.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedMar 2026
$11.3M

Sign up to see all 6 events

Funding: Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nanochon on Indexed.vc
<a href="https://indexed.vc/companies/nanochon"><img src="https://indexed.vc/api/badge/company/nanochon" alt="Nanochon on Indexed.vc" width="260" height="76" /></a>